Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/30/2872162/0/en/Processa-Pharmaceuticals-Names-Dr-Steven-Cha-Senior-Vice-President-of-Clinical-Research.html
https://www.globenewswire.com/news-release/2024/04/11/2861459/0/en/Processa-Pharmaceuticals-Presents-Two-Abstracts-at-the-AACR-Annual-Meeting-2024-Including-New-Data-on-the-NGC-Cap-Phase-1b-Trial.html
https://www.globenewswire.com/news-release/2024/03/28/2853979/0/en/Processa-Pharmaceuticals-to-Present-at-the-MedInvest-Biotech-and-Pharma-Investor-Conference.html
https://www.globenewswire.com/news-release/2024/03/25/2851598/0/en/Processa-Pharmaceuticals-to-Present-Data-at-the-American-Association-for-Cancer-Research-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/21/2832738/0/en/Processa-Pharmaceuticals-to-Present-at-the-2024-BIO-CEO-Investor-Conference.html
https://www.globenewswire.com//news-release/2024/02/14/2829368/0/en/Processa-Pharmaceuticals-to-Present-at-The-Winter-Wrap-Up-MicroCap-Rodeo-Winter-2024-Virtual-Conference.html
https://www.globenewswire.com//news-release/2024/02/06/2824321/0/en/Processa-Pharmaceuticals-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Rule.html
https://www.globenewswire.com//news-release/2024/02/01/2822471/0/en/Processa-Pharmaceuticals-Announces-Closing-of-7-0-Million-Public-Offering.html
https://www.globenewswire.com//news-release/2024/01/26/2817975/0/en/Processa-Pharmaceuticals-Announces-Pricing-of-7-0-Million-Public-Offering.html
https://www.globenewswire.com//news-release/2024/01/25/2816773/0/en/Processa-Pharmaceuticals-Announces-Successful-Completion-of-Phase-1b-Safety-Evaluation-of-NGC-Cap-in-Patients-with-Advanced-Cancer-Resulting-in-Recommended-Phase-2-Doses.html